Skip to main content

Clifford Chance

Clifford Chance
All
Briefings

Briefings

In this section

India tightens norms for pharma M&A

10 November 2011

On 8 November 2011, the Indian government amended its foreign investment rules imposing a requirement to seek its approval for foreign direct investment ("FDI") in existing Indian pharmaceutical companies. FDI in greenfield pharmaceutical ventures can be made without the requirement of any such approval.

Download PDF
  • Share on Twitter
  • Share on LinkedIn
  • Share via email
Back to top

Toolkits & Client Log-in